Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Pearson

Showing results (191-200 of 206) with videos related to

Pageof 21
Sort By:
British Journal of Haematology|September 1, 1999
The management of 'low-risk' and 'intermediate-risk' patients with primary thrombocythaemia. MPD (UK) Study GroupT C Pearson, D Bareford, J Craig, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 20, 2008
Expanded nonhuman primate tregs exhibit a unique gene expression signature and potently downregulate alloimmune responsesA Anderson, C L Martens, R Hendrix, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 14, 2006
A mouse model for polyomavirus-associated nephropathy of kidney transplantsE D Han Lee, C C Kemball, J Wang, et al.
British Journal of Haematology|July 21, 2005
Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosisMary F McMullin, D Bareford, P Campbell, et al.
Transplantation|June 30, 1998
Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockadeE T Elwood, C P Larsen, H R Cho, et al.
Nature|May 30, 1996
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathwaysC P Larsen, E T Elwood, D Z Alexander, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 2, 2014
Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitorsA D Kirk, A Guasch, H Xu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivoM Niimi, T C Pearson, C P Larsen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 26, 2017
Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft FunctionA B Adams, J Goldstein, C Garrett, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 2, 2010
Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantationN A Turgeon, J G Avila, J A Cano, et al.
Pageof 21

Showing results (191-200 of 206) with videos related to

Sort By:
Pageof 21
British Journal of Haematology|September 1, 1999
The management of 'low-risk' and 'intermediate-risk' patients with primary thrombocythaemia. MPD (UK) Study GroupT C Pearson, D Bareford, J Craig, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 20, 2008
Expanded nonhuman primate tregs exhibit a unique gene expression signature and potently downregulate alloimmune responsesA Anderson, C L Martens, R Hendrix, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 14, 2006
A mouse model for polyomavirus-associated nephropathy of kidney transplantsE D Han Lee, C C Kemball, J Wang, et al.
British Journal of Haematology|July 21, 2005
Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosisMary F McMullin, D Bareford, P Campbell, et al.
Transplantation|June 30, 1998
Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockadeE T Elwood, C P Larsen, H R Cho, et al.
Nature|May 30, 1996
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathwaysC P Larsen, E T Elwood, D Z Alexander, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 2, 2014
Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitorsA D Kirk, A Guasch, H Xu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivoM Niimi, T C Pearson, C P Larsen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 26, 2017
Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft FunctionA B Adams, J Goldstein, C Garrett, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 2, 2010
Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantationN A Turgeon, J G Avila, J A Cano, et al.
Pageof 21